SCHEMBL16368696

SCHEMBL16368696

O=C(c1ccc2c(c1)OCc1cc(C(=O)C(Br)Br)sc1-2)C(Br)Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.51
GAA P10253 9/20 0.51
KDM4E B2RXH2 8/20 0.51
HPGD P15428 8/20 0.51
HSD17B10 Q99714 5/20 0.51
NOTUM Q6P988 5/20 0.51
MAPK1 P28482 3/20 0.51
MAPT P10636 6/20 0.47
GLA P06280 4/20 0.47
HTT P42858 4/20 0.47
CASP1 P29466 3/20 0.47
CASP7 P55210 3/20 0.47
TP53 P04637 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
STAT3 P40763 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
TSHR P16473 2/20 0.47
ATM Q13315 1/20 0.47
PIK3CA P42336 5/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16368697 0.88 NOTUM (0.53) NOTUMPIK3CA
SCHEMBL16368693 0.79 KDM4E (0.47) ALDH1A1GAAKDM4EHPGDNOTUM
SCHEMBL15173555 0.78 KDM4E (0.63) ALDH1A1GAAKDM4EHPGDHSD17B10
SCHEMBL15172972 0.78 ALDH1A1 (0.51) ALDH1A1GAAKDM4EHPGDHSD17B10
SCHEMBL15173197 0.72 ALDH1A1 (0.62) ALDH1A1GAAKDM4EHPGDHSD17B10
SCHEMBL15188504 0.71 RAB9A (0.42) ALDH1A1KDM4EHPGDMAPK1MAPT
SCHEMBL15188517 0.71 NPC1 (0.45) ALDH1A1HPGDTP53SMN1; SMN2TSHR
SCHEMBL20597636 0.70 NOTUM (0.81) ALDH1A1GAAKDM4EHPGDHSD17B10
SCHEMBL20597657 0.70 NOTUM (0.81) ALDH1A1GAAKDM4EHPGDHSD17B10
SCHEMBL20597360 0.69 NOTUM (0.63) ALDH1A1GAAKDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073942-B2 Antiviral compounds with a heterotricycle moiety LUPIN LIMITED (IN) 2015-07-07 US disclosed
US-20150010504-A1 Antiviral Compounds with a Heterotricycle Moiety LUPIN LIMITED (IN) 2015-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150010504-A1 Antiviral Compounds with a Heterotricycle Moiety HCCS, UQCRB, HAVCR2 ALDH1A1 2083/4885GAA 1402/4885KDM4E 3535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.